About us

Kugelmeiers Ltd. was founded in 2015 as a spin-off from the University of Zurich in Switzerland.

The company originated from the University Hospital of Zurich’s human islet cell transplantation clinical program for the treatment of diabetes. The core business is the translation of novel insights of biological realities of cells into products that are optimally suited for 3D cell culture and cell transplantation. The company’s expertise in cell transplantation, 3D cell culture and stem cell biology addresses an increasingly growing market.

In order to drive the development of promising future cell therapies, Kugelmeiers Ltd. cooperates with leading scientists, institutes, laboratories and industry partners worldwide.

For more information please visit our company page:

www.kugelmeiers.com

Sandra H. Kugelmeier-Heller

CEO

  

Dr. med. Patrick Kugelmeier

Medical Director

  

Dr. Manfred Vogel

Director of Life Sciences

  

Urs Gremlich

Purchasing & Logistics

  

GUILLAUME JUNG

Production & Technology

  

Dr. Markus Mühlemann

Senior Scientist Translational Research & Clinical Studies

  

KAROLINA PAL-KUTAS

GMP / ATMP Specialist

  

This website uses cookies to provide services and analyze access. By continuing to use this site, you consent to our cookie policy. learn more